Feldman R I, Bartholdi M F, Wu J M
Department of Protein Biochemistry and Biophysics, Berlex Biosciences, Richmond, California 94804-0099, USA.
Mol Pharmacol. 1996 Nov;50(5):1346-54.
Bombesin-like peptides (BLPs) can regulate the growth of normal and transformed cells. To compare the relative activities of the three known human BLP receptor subtypes [i.e., the gastrin-releasing peptide (GRP) receptor, neuromedin B (NMB) receptor, or BLP receptor subtype 3] in growth regulation, we expressed each receptor in a receptor-deficient host, Balb/3T3 cells. None of the receptor agonists used in our study promoted DNA synthesis by quiescent parental, nontransfected Balb/3T3 cells. Using clones stably transfected with the NMB receptor however, we found that NMB stimulated the incorporation of [3H]thymidine 2.5- to 8-fold over basal levels. The greatest net stimulation of [3H]thymidine incorporation occurred when the medium contained insulin. In quiescent Balb/3T3 cells transfected with the GRP receptor, GRP promoted a 15-fold increase in DNA synthesis in the absence of insulin or other growth factors. GRP also induced the labeling of a large percentage (53%) of the cells with bromodeoxyuridine. To determine the length of time that GRP receptor signaling was required to drive quiescent cells into the S phase of the cell cycle, we blocked GRP receptor signaling by addition of a competitive GRP receptor antagonist at different times after stimulating cells with GRP. Our data demonstrate that persistent GRP receptor signaling throughout a large part of the G1 phase of the cell cycle is important in the mitogenic effects of GRP in these cells. Hitherto uncharacterized GRP receptor signaling pathways may be important in this process. BLPs also stimulated a mitogenic response by transfectants expressing the BLP receptor subtype 3 if insulin was contained in the medium. Taken together, these studies indicate that all three BLP receptor subtypes may contribute to growth regulation in vivo.
蛙皮素样肽(BLPs)可调节正常细胞和转化细胞的生长。为比较三种已知的人BLP受体亚型[即胃泌素释放肽(GRP)受体、神经降压素B(NMB)受体或BLP受体亚型3]在生长调节中的相对活性,我们在缺乏受体的宿主细胞Balb/3T3细胞中表达了每种受体。我们研究中使用的任何一种受体激动剂都不能促进静止的亲代未转染Balb/3T3细胞的DNA合成。然而,使用稳定转染了NMB受体的克隆,我们发现NMB刺激[3H]胸腺嘧啶核苷掺入量比基础水平高2.5至8倍。当培养基中含有胰岛素时,[3H]胸腺嘧啶核苷掺入量的净刺激最大。在转染了GRP受体的静止Balb/3T3细胞中,GRP在没有胰岛素或其他生长因子的情况下促进DNA合成增加15倍。GRP还诱导了很大比例(53%)的细胞被溴脱氧尿苷标记。为了确定GRP受体信号传导驱动静止细胞进入细胞周期S期所需的时间,我们在GRP刺激细胞后的不同时间添加竞争性GRP受体拮抗剂来阻断GRP受体信号传导。我们的数据表明,在细胞周期的大部分G1期持续的GRP受体信号传导在GRP对这些细胞的促有丝分裂作用中很重要。迄今未被表征的GRP受体信号传导途径在此过程中可能很重要。如果培养基中含有胰岛素,BLPs也会通过表达BLP受体亚型3的转染细胞刺激有丝分裂反应。综上所述,这些研究表明所有三种BLP受体亚型可能在体内生长调节中发挥作用。